期刊论文详细信息
Allergy, Asthma & Clinical Immunology
Vitamin C and common cold-induced asthma: a systematic review and statistical analysis
Harri Hemilä1 
[1] Department of Public Health, POB 41, University of Helsinki, Mannerheimintie 172, FIN-00014 Helsinki, Finland
关键词: Upper respiratory tract infections;    Rhinovirus;    Histamine;    Forced expiratory flow rates;    Common cold;    Bronchoconstriction;    Bronchial provocation tests;    Asthma;    Ascorbic acid;    Anti-asthmatic agents;   
Others  :  792065
DOI  :  10.1186/1710-1492-9-46
 received in 2013-06-26, accepted in 2013-11-07,  发布年份 2013
PDF
【 摘 要 】

Background

Asthma exacerbations are often induced by the common cold, which, in turn, can be alleviated by vitamin C.

Objective

To investigate whether vitamin C administration influences common cold-induced asthma.

Methods

Systematic review and statistical analysis of the identified trials. Medline, Scopus and Cochrane Central were searched for studies that give information on the effects of vitamin C on common cold-induced asthma. All clinically relevant outcomes related to asthma were included in this review. The estimates of vitamin C effect and their confidence intervals [CI] were calculated for the included studies.

Results

Three studies that were relevant for examining the role of vitamin C on common cold-induced asthma were identified. The three studies had a total of 79 participants. Two studies were randomized double-blind placebo-controlled trials. A study in Nigeria on asthmatics whose asthma attacks were precipitated by respiratory infections found that 1 g/day vitamin C decreased the occurrence of asthma attacks by 78% (95% CI: 19% to 94%). A cross-over study in former East-Germany on patients who had infection-related asthma found that 5 g/day vitamin C decreased the proportion of participants who had bronchial hypersensitivity to histamine by 52 percentage points (95% CI: 25 to 71). The third study did not use a placebo. Administration of a single dose of 1 gram of vitamin C to Italian non-asthmatic common cold patients increased the provocative concentration of histamine (PC20) 3.2-fold (95% CI: 2.0 to 5.1), but the vitamin C effect was significantly less when the same participants did not suffer from the common cold.

Conclusions

The three reviewed studies differed substantially in their methods, settings and outcomes. Each of them found benefits from the administration of vitamin C; either against asthma attacks or against bronchial hypersensitivity, the latter of which is a characteristic of asthma. Given the evidence suggesting that vitamin C alleviates common cold symptoms and the findings of this systematic review, it may be reasonable for asthmatic patients to test vitamin C on an individual basis, if they have exacerbations of asthma caused by respiratory infections. More research on the role of vitamin C on common cold-induced asthma is needed.

【 授权许可】

   
2013 Hemilä; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140705023912202.pdf 271KB PDF download
Figure 1. 26KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Rosenthal LA, Avila PC, Heymann PW, Martin RJ, Miller EK, Papadopoulos NG, Peebles RS, Gern JE: Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol 2010, 125:1212-1217. http://dx.doi.org/10.1016/j.jaci.2010.04.002 webcite
  • [2]Minor TE, Dick EC, DeMeo AN, Ouellette JJ, Cohen M, Reed CE: Viruses as precipitants of asthmatic attacks in children. JAMA 1974, 227:292-298. http://dx.doi.org/10.1001/jama.1974.03230160020004 webcite
  • [3]Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982-986. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1679193 webcite
  • [4]Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Symington P, O’Toole S, Myint SH, Tyrrell DA: Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995, 310:1225-1229. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2549614 webcite
  • [5]Gern JE: The ABCs of rhinoviruses, wheezing, and asthma. J Virol 2010, 84:7418-7426. http://dx.doi.org/10.1128/JVI.02290-09 webcite, http://www.ncbi.nlm.nih.gov/pubmed/20375160 webcite
  • [6]Walter MJ, Castro M, Kunselman SJ, Chinchilli VM, Reno M, Ramkumar TP, Avila PC, Boushey HA, Ameredes BT, Bleecker ER, Calhoun WJ, Cherniack RM, Craig TJ, Denlinger LC, Israel E, Fahy JV, Jarjour NN, Kraft M, Lazarus SC, Lemanske RF Jr, Martin RJ, Peters SP, Ramsdell JW, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Wechsler ME: National Heart, Lung and Blood Institute’s Asthma Clinical Research Network: Predicting worsening asthma control following the common cold. Eur Respir J 2008, 32:1548-1554. http://dx.doi.org/10.1183/09031936.00026808 webcite
  • [7]Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA: Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976, 113:131-139. http://www.ncbi.nlm.nih.gov/pubmed/1247226 webcite
  • [8]Grünberg K, Timmers MC, Smits HH, de Klerk EP, Dick EC, Spaan WJ, Hiemstra PS, Sterk PJ: Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997, 27:36-45. http://www.ncbi.nlm.nih.gov/pubmed/9117878 webcite
  • [9]Grünberg K, Timmers MC, de Klerk EP, Dick EC, Sterk PJ: Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999, 160:1375-1380. http://www.ncbi.nlm.nih.gov/pubmed/10508832 webcite
  • [10]Lemanske RF, Dick EC, Swenson CA, Vrtis RF, Busse WW: Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989, 83:1-10. http://www.ncbi.nlm.nih.gov/pubmed/2536042 webcite
  • [11]Cheung D, Dick EC, Timmers MC, de Klerk EP, Spaan WJ, Sterk PJ: Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995, 152:1490-1496. http://www.ncbi.nlm.nih.gov/pubmed/7582282 webcite
  • [12]Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST: Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995, 151:879-886. http://www.ncbi.nlm.nih.gov/pubmed/7881686 webcite
  • [13]Carpenter KJ: The History of Scurvy and Vitamin C. New York, NY: Cambridge University Press; 1986.
  • [14]Hemilä H: Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition 1996, 12:804-809. http://hdl.handle.net/10250/7979 webcite, http://dx.doi.org/10.1016/S0899-9007(96)00223-7 webcite
  • [15]Hemilä H: Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med Hypotheses 1999, 52:171-178. http://hdl.handle.net/10250/8375 webcite, http://dx.doi.org/10.1054/mehy.1997.0639 webcite
  • [16]Hemilä H, Chalker EB: Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013, 1:CD000980. http://dx.doi.org/10.1002/14651858.CD000980.pub4 webcite
  • [17]Hemilä H: Do vitamins C and E affect respiratory infections. Helsinki, Finland: University of Helsinki; 2006:11-16. [PhD Thesis] 46–51, 62–63. http://hdl.handle.net/10138/20335 webcite
  • [18]Hemilä H: Vitamin C intake and susceptibility to the common cold. [discussion in: 1997, 78:857–866]. Br J Nutr 1997, 77:59-72. http://dx.doi.org/10.1017/S0007114500002889 webcite
  • [19]Elwood PC, Lee HP, St Leger AS, Baird M, Howard AN: A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold. Br J Prev Soc Med 1976, 30:193-196. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC478963 webcite
  • [20]Anderson TW, Reid DBW, Beaton GH: Vitamin C and the common cold [correction of: 1972, 107:503–508]. Can Med Assoc J 1973, 108:133. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941144 webcite
  • [21]Hemilä H, Louhiala P: Vitamin C may affect lung infections. J R Soc Med 2007, 100:495-498. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2099400 webcite
  • [22]Goldsmith GA, Ogaard AT, Gowe DF: Vitamin C (ascorbic acid) nutrition in bronchial asthma: an estimation of the daily requirement of ascorbic acid. Arch Intern Med 1941, 67:597-608.
  • [23]Silbert NE: Vitamin C: a critical review of the use of vitamin C in allergic disorders and a preliminary report comparing it therapeutically with antihistamines, antiasthmatics and sedatives. Med Times 1951, 79:370-376. http://www.ncbi.nlm.nih.gov/pubmed/14852293 webcite
  • [24]Hemilä H: Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis. BMJ Open 2013, 3:e002416. http://dx.doi.org/10.1136/bmjopen-2012-002416 webcite
  • [25]Bucca C, Rolla G, Arossa W, Caria E, Elia C, Nebiolo F, Baldi S: Effect of ascorbic acid on increased bronchial responsiveness during upper airway infection. Respiration 1989, 55:214-219. http://www.ncbi.nlm.nih.gov/pubmed/2595105 webcite, http://dx.doi.org/10.1159/000195737 webcite
  • [26]Bucca C, Rolla G, Farina JC: Effect of vitamin C on transient increase of bronchial responsiveness in conditions affecting the airways. Ann NY Acad Sci 1992, 669:175-187. http://www.ncbi.nlm.nih.gov/pubmed/1444023 webcite, http://dx.doi.org/10.1111/j.1749-6632.1992.tb17098.x webcite
  • [27]Anah CO, Jarike LN, Baig HA: High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 1980, 32:132-137. http://www.ncbi.nlm.nih.gov/pubmed/7423602 webcite
  • [28]The R Project for Statistical Computing http://www.r-project.org webcite
  • [29]Glynn RJ, Buring JE: Ways of measuring rates of recurrent events. BMJ 1996, 312:364-367. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350293 webcite
  • [30]Schertling M, Winsel K, Müller S, Henning R, Meiske W, Slapke J: Action of ascorbic acid on clinical course of infection related bronchial asthma and on reactive oxygen metabolites by BAL cells [in German]. Z Klin Med 1990, 45:1770-1774. English translation available at: http://www.mv.helsinki.fi/home/hemila/T9.pdf webcite
  • [31]Schertling M: Einfluss von Ascorbinsäure auf den klinischen Verlauf des infektbedingten Asthma bronchiale und die Bildung von reaktiven Sauerstoffmetaboliten durch BAL-Zellen. Berlin, East Germany: PhD thesis; 1989. Excerpts available at: http://www.mv.helsinki.fi/home/hemila/A/Schertling.htm webcite
  • [32]Fagerland MW, Lydersen S, Laake P: Recommended confidence intervals for two independent binomial proportions. Stat Methods Med Res 2011. (in press). http://dx.doi.org/10.1177/0962280211415469 webcite
  • [33]Nathan RA, Segall N, Glover GC, Schocket AL: The effects of H1 and H2 antihistamines on histamine inhalation challenges in asthmatic patients. Am Rev Respir Dis 1979, 120:1251-1258. http://www.ncbi.nlm.nih.gov/pubmed/42333 webcite
  • [34]Malo JL, Fu CL, L’Archevêque J, Ghezzo H, Cartier A: Duration of the effect of astemizole on histamine-inhalation tests. J Allergy Clin Immunol 1990, 85:729-736. http://www.ncbi.nlm.nih.gov/pubmed/1969870 webcite
  • [35]Lemire I, Cartier A, Malo JL, Pineau L, Ghezzo H, Martin RR: Effect of sodium cromoglycate on histamine inhalation tests. J Allergy Clin Immunol 1984, 73:234-239. http://www.ncbi.nlm.nih.gov/pubmed/6421918 webcite
  • [36]Strban M, Manning PJ, Watson RM, O’Byrne PM: Effect of magnitude of airway responsiveness and therapy with inhaled corticosteroid on histamine tachyphylaxis in asthma. Chest 1994, 105:1434-1438. http://www.ncbi.nlm.nih.gov/pubmed/8181332 webcite
  • [37]Schoeffel RE, Anderson SD, Gillam I, Lindsay DA: Multiple exercise and histamine challenge in asthmatic patients. Thorax 1980, 35:164-170. http://dx.doi.org/10.1136/thx.35.3.164 webcite
  • [38]Ruffin RE, Alpers JH, Crockett AJ, Hamilton R: Repeated histamine inhalation tests in asthmatic patients. J Allergy Clin Immunol 1981, 67:285-289. http://www.ncbi.nlm.nih.gov/pubmed/7204784 webcite
  • [39]Polosa R, Finnerty JP, Holgate ST: Tachyphylaxis to inhaled histamine in asthma: its significance and relationship to basal airway responsiveness. J Allergy Clin Immunol 1990, 86:265-271. http://www.ncbi.nlm.nih.gov/pubmed/2384654 webcite
  • [40]Roorda RJ, Gerritsen J, van Aalderen WM, Schouten JP, Knol K: Repeated provocation tests in asthmatic children for testing tachyphylaxis to histamine. Pediatr Pulmonol 1991, 10:106-111. http://dx.doi.org/10.1002/ppul.1950100212 webcite
  • [41]Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000, 161:309-329. http://www.ncbi.nlm.nih.gov/pubmed/10619836 webcite
  • [42]Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999, 159:1043-1051. http://www.ncbi.nlm.nih.gov/pubmed/10194144 webcite
  • [43]Fajt ML, Wenzel SE: Asthma phenotypes in adults and clinical implications. Expert Rev Respir Med 2009, 3:607-625. http://www.ncbi.nlm.nih.gov/pubmed/20477351 webcite, http://dx.doi.org/10.1586/ers.09.57 webcite
  • [44]Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011, 127:355-360.
  • [45]Fogarty A, Lewis SA, Scrivener SL, Antoniak M, Pacey S, Pringle M, Britton J: Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial. Clin Exp Allergy 2003, 33:1355-1359. http://dx.doi.org/10.1046/j.1365-2222.2003.01777.x webcite
  • [46]Fogarty A, Lewis SA, Scrivener SL, Antoniak M, Pacey S, Pringle M, Britton J: Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respir Med 2006, 100:174-179. http://dx.doi.org/10.1016/j.rmed.2005.03.038 webcite
  • [47]Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M: Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 2010, 5:e11414. http://dx.doi.org/10.1371/journal.pone.0011414 webcite
  文献评价指标  
  下载次数:16次 浏览次数:20次